India’s biotech sector is powering ahead, with 30 per cent annual growth over the past four years. But venture capitalists are still not tempted to invest.
Can European R&D play its way to the top of the international league? In an unprecedented gathering Science|Business brought together some of the leading protagonists to discuss possible tactics.
The European Commission and the European Investment Bank have set up a €2 billion risk-sharing finance facility to support research and innovation in Europe.
The EU and Japan agreed to strengthen their research ties at a summit last week with plans to improve cooperation and the protection of intellectual property rights
EU governments have resigned themselves to the fact that the Galileo satellite navigation network will have to financed from the public purse – but failed to agree where the money will come from.
Entrepreneurs are important to creating jobs and prosperity in Europe; most politicians recognise that nowadays. But what’s less obvious is that when it comes to creating new businesses, sheer numbers don’t make for a dynamic economy.
Novo Nordisk is doing its bit to reverse the Danish brain drain, offering a number of “return” fellowships to attract highly qualified expatriates back to Denmark.
The claim that over-patenting hinders the development of new treatments is not supported by the evidence, says the US Biotechnology Industry Organization.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.